Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)
China flag China · Delayed Price · Currency is CNY
9.12
-0.03 (-0.33%)
Nov 13, 2026, 3:04 PM CST

SHE:002728 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Revenue
856.22924.53687.791,067886.57758.16
Revenue Growth
-7.34%34.42%-35.55%20.38%16.94%19.83%
Gross Profit
465.22503.36301.32599.23434.74402.04
Operating Income
67.3180.8230.43306.04217.99177.33
Net Income
65.981.6720.5253.18178.2126.92
Earnings Per Share
0.130.160.040.550.410.32
EPS Growth
-28.31%300.00%-92.73%35.10%28.71%181.91%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
Pharmaceutical Industry
908.06671.611,051
Pharmaceutical Business
9.469.4610.74
Chemical Products and Others
7.016.715.84
Total
924.53687.791,067

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Investments
491.6336.15457.41647.25739.66372.47
Total Debt
387.46263.54516.09306847.18662.18
Net Cash (Debt)
104.1372.61-58.68341.25-107.52-289.71
Net Cash Growth
87.97%-----
Net Cash Per Share
0.210.14-0.110.74-0.25-0.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Cash Flow
120.04244.09-22.55198.56371.66256.81
Capital Expenditures
-71.68-79.55-113.56-86.05-90.26-109.58
Free Cash Flow
48.35164.54-136.11112.51281.39147.24
Free Cash Flow Growth
-57.64%---60.02%91.11%85.05%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Gross Margin
54.33%54.45%43.81%56.15%49.04%53.03%
Operating Margin
7.86%8.74%4.42%28.68%24.59%23.39%
Pretax Margin
7.97%8.90%3.21%27.45%22.14%19.40%
Profit Margin
7.70%8.83%2.98%23.72%20.10%16.74%
FCF Margin
5.65%17.80%-19.79%10.54%31.74%19.42%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Dividend Per Share
0.1500.1500.0500.3570.3320.332
Dividend Per Share Growth
200.00%200.00%-86.00%7.69%0%0%
Dividend Yield
1.65%1.38%0.56%2.80%2.98%3.80%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PE Ratio
69.9066.33217.4725.7228.0529.90
Forward PE
-26.4614.16---
P/FCF Ratio
96.6532.92-57.8717.7625.77
PS Ratio
5.465.866.486.105.645.01